Abstract:Objectives: Moyamoya Disease (MMD) is a progressive occlusive cerebrovascular disease with unknown etiology and pathogenesis. Studies have reported dysregulation in extracellular matrix-related molecules and increased circulating inflammatory cytokines/chemokines in MMD patients, suggesting a role of immune responses in the development of MMD. In this study, we utilized single-cell RNA sequencing (scRNA-seq) to investigate the circulating transcriptome immune cell signatures in MMD. Methods: Whole blood samples were collected from bilateral MMD (n=3), non-MMD patients (n=2, aneurysm, or cavernous malformation) and healthy controls (HC) (n=2). Peripheral blood mononuclear cells (PBMCs) were isolated and cryopreserved. Single Cell 3’ Gene Expression libraries were generated and sequenced. Data were demultiplexed and mapped using the CellRanger. Differentially expressed genes (DEGs) were identified and top biological functions and pathways in each cell type were analyzed. Results: ScRNA-seq data showed differences in several key cell types between MMD and HC, such as CD8+ NKT, Naïve CD8+ T, CD4+ NKT, Naïve B cells and non-classical monocytes. Further analyses of DEGs for CD8+ NKT, Naïve CD8+ T and CD4+ NKT highlighted in MMD revealed a predicted activation in cell death and predicted inhibition in cell viability, cell movement, proliferation, and migration. In addition, eIF2 (eukaryotic initiation factor-2) activation was detected in all three cell types, most prominently in CD8+ NKT cells. Pathway analysis revealed an inhibition in natural killer cell signaling and autophagy pathways. Conclusion: In this study, we identified circulating immune cell signatures in MMD and highlighted the role of CD8+ NKT cells, Naïve CD8+ T cells and CD4+ NKT cells. These cell types manifest distinct pathological processes involved in cellular stress, including inhibition of natural killer cell signaling and disruption in autophagy, which can lead to impaired cytotoxic functions. Active investigations address validation of key cell-type and genes with additional patient cohort. This investigation elucidates the intricate immune responses associated with MMD, providing integral insights for discerning the disease's pathophysiology.

Proteomics and digital subtraction angiography approaches reveal CDH18 as a potential target for therapy of moyamoya disease

Differential Expression of Vascular Endothelial Growth Factor-A165 Isoforms Between Intracranial Atherosclerosis and Moyamoya Disease.

Proteomic Profiling of Exosomes From Hemorrhagic Moyamoya Disease and Dysfunction of Mitochondria in Endothelial Cells.

Organoid Modeling and Single-Cell Profiling Uncover the Migration Mechanism of Smooth Muscle Cells in Moyamoya Disease

Transcriptomic Profiling of Intracranial Arteries in Adult Patients With Moyamoya Disease Reveals Novel Insights Into Its Pathogenesis

Bioinformatics analysis reveals the landscape of immune cell infiltration and novel immune-related biomarkers in moyamoya disease

Exosomal MicroRNAs: Biomarkers of moyamoya disease and involvement in vascular cytoskeleton reconstruction

Serum miRNA Signature in Moyamoya Disease

Integrated Analysis of LncRNA-mRNA Co-Expression Profiles in Patients with Moyamoya Disease

Comprehensive Analysis and In Vitro Verification of Endothelial-Mesenchymal Transition-Related Genes in Moyamoya Disease

Comprehensive Serum Proteomic and Metabolomic Profiles of Pediatric Patients with Moyamoya Disease Reveal Core Pathways

Identification of diagnostic markers for moyamoya disease by combining bulk RNA-sequencing analysis and machine learning

Identification of lysosome-related hub genes as potential biomarkers and immune infiltrations of moyamoya disease by multiple bioinformatics methods and machine-learning strategies

Molecular Biomarkers Affecting Moyamoya Disease

The Susceptibility Pathogenesis of Moyamoya Disease

Abstract P749: Functional and Molecular Characterization of Endothelial and Vascular Smooth Muscle Cells Derived From Moyamoya Disease-Induced Pluripotent Stem Cells

A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya Disease

PHACTR1 is associated with disease progression in Chinese Moyamoya disease.

Abstract TP284: Transcriptome Profiling of Peripheral Blood Mononuclear Cells in Moyamoya Disease

Data-Independent Acquisition-Based Serum Proteomic Profiling of Adult Moyamoya Disease Patients Reveals the Potential Pathogenesis of Vascular Changes.

Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice